Suchergebnisse - "ritonavir"

PubPharm (9.313)

51

Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients

enthalten in: Cancers | 2024

von Haddad, A. | Hachem, R. | Moussa, M. | +5

52

COVID-19 Rebound After VV116 vs Nirmatrelvir-Ritonavir Treatment : A Randomized Clinical Trial

enthalten in: JAMA network open | 2024

von Yang, Z. | Xu, Y. | Zheng, R. | +28

53

Nirmatrelvir/ritonavir for COVID-19 : an overview of systematic reviews

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Cruciani, M. | Pati, I. | Masiello, F. | +2

54

Evaluation of physicians prescribing of COVID-19 guideline-directed outpatient treatments in a primary care walk-in clinic

enthalten in: Journal of the American Pharmacists Association : JAPhA | 2024

von Denning, K. | Sheppard, J. | Carico, R.

55

Safety and Pharmacokinetics of Lopinavir/Ritonavir Oral Solution in Preterm and Term Infants Starting Before 3 Months of Age

enthalten in: The Pediatric infectious disease journal | 2024

von Bekker, A. | Yang, J. | Wang, J. | +11

56

Emerging data in COVID-19 create urgent challengers for health providers : Updates on COVID-19 vaccine and Paxlovid

enthalten in: Journal of the National Medical Association | 2024

von Mejia, M. | Mitchell, J. | Dumpa, M. | +4

57

Small-molecule antiviral treatments for COVID-19 : A systematic review and network meta-analysis

enthalten in: International journal of antimicrobial agents | 2024

von Zheng, B. | Zhao, Q. | Yang, W. | +8

58

Physicochemical interaction of rifampicin and ritonavir-lopinavir solid dispersion : an in-vitro and ex-vivo investigation

enthalten in: Drug development and industrial pharmacy | 2024

von Nair, A. | Vullendula, S. | Yarlagadda, D. | +3

59

Combined protection of vaccination and nirmatrelvir-ritonavir against hospitalization in adults with COVID-19

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Shah, M. | Joyce, B. | Plumb, I. | +8

60

Effect of Hepatic Impairment on the Pharmacokinetics of Nirmatrelvir/Ritonavir, the First Oral Protease Inhibitor for the Treatment of COVID-19

enthalten in: Journal of clinical pharmacology | 2024

von Singh, R. | LaBadie, R. | Toussi, S. | +4